|
COMPASS MINERALS INTERNATIONAL INC |
Safran David |
Director
|
2025-12-18 |
Acquisition (Non Open Market) |
1,348 |
0.00 |
0.00 |
1,348 |
| KLRS |
Kalaris Therapeutics, Inc. |
Samsara Opportunity Fund GP, LLC |
10% Owner
|
2025-12-18 |
Buy |
479,847 |
10.42 |
5,000,005.74 |
1,979,847 |
| CFND |
C1 Fund Inc. |
Singer Jeffrey H. |
Director
|
2025-12-18 |
Buy |
2,000 |
4.89 |
9,780.00 |
2,000 |
| FDS |
FACTSET RESEARCH SYSTEMS INC |
Skoko Goran |
Officer
|
2025-12-18 |
Acquisition (Non Open Market) |
7 |
273.39 |
1,932.10 |
9,205 |
| FDS |
FACTSET RESEARCH SYSTEMS INC |
Stepp Katherine M |
Officer
|
2025-12-18 |
Acquisition (Non Open Market) |
0 |
273.39 |
0.19 |
808 |
| PSNL |
Personalis, Inc. |
Tempus AI, Inc. |
|
2025-12-18 |
Buy |
31,430 |
7.91 |
248,611.30 |
12,981,426 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Young Caroline |
Director
|
2025-12-18 |
Acquisition (Non Open Market) |
3 |
4.19 |
12.57 |
33,290 |
| BCV |
BANCROFT FUND LTD |
Dinsmore James Andrew |
Director
Officer
|
2025-12-17 |
Buy |
220 |
21.50 |
4,730.00 |
990 |
| ECF |
ELLSWORTH GROWTH & INCOME FUND LTD |
Dinsmore James Andrew |
Director
Officer
|
2025-12-17 |
Buy |
200 |
11.60 |
2,320.00 |
12,292 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Jones James |
Director
|
2025-12-17 |
Acquisition (Non Open Market) |
10 |
3.65 |
36.50 |
44,991 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
KAZIMI A J |
Director
Officer
10% Owner
|
2025-12-17 |
Acquisition (Non Open Market) |
10 |
3.65 |
36.50 |
5,701,083 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Krogulski Kenneth |
Director
|
2025-12-17 |
Acquisition (Non Open Market) |
67 |
3.65 |
244.55 |
296,037 |
| PSNL |
Personalis, Inc. |
Tempus AI, Inc. |
|
2025-12-17 |
Buy |
31,650 |
7.86 |
248,769.00 |
12,949,996 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Young Caroline |
Director
|
2025-12-17 |
Acquisition (Non Open Market) |
3 |
3.65 |
10.95 |
33,287 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Jones James |
Director
|
2025-12-16 |
Acquisition (Non Open Market) |
14 |
3.27 |
45.78 |
44,981 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
KAZIMI A J |
Director
Officer
10% Owner
|
2025-12-16 |
Acquisition (Non Open Market) |
14 |
3.27 |
45.78 |
5,701,073 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Krogulski Kenneth |
Director
|
2025-12-16 |
Acquisition (Non Open Market) |
104 |
3.27 |
340.08 |
295,970 |
| NONE |
Stellus Private Credit BDC |
Legacy Knight Strategic Opportunities Fund - SCM Series |
10% Owner
|
2025-12-16 |
Buy |
56,624 |
15.26 |
864,082.24 |
1,102,747 |
| SNDR |
Schneider National, Inc. |
Schneider Paul J. |
10% Owner
|
2025-12-16 |
Disposition (Non Open Market) |
5,600 |
0.00 |
0.00 |
395,763 |
| SNDR |
Schneider National, Inc. |
Schneider Paul J. |
10% Owner
|
2025-12-16 |
Acquisition (Non Open Market) |
2,800 |
0.00 |
0.00 |
398,563 |
| CPIX |
CUMBERLAND PHARMACEUTICALS INC |
Young Caroline |
Director
|
2025-12-16 |
Acquisition (Non Open Market) |
3 |
3.27 |
9.81 |
33,284 |
| EXFY |
Expensify, Inc. |
Barrett David Michael |
Director
Officer
|
2025-12-15 |
Acquisition (Non Open Market) |
14,463 |
0.00 |
0.00 |
227,030 |
|
Expensify, Inc. |
Barrett David Michael |
Director
Officer
|
2025-12-15 |
Disposition (Non Open Market) |
14,463 |
0.00 |
0.00 |
216,947 |
|
Expensify, Inc. |
Barrett David Michael |
Director
Officer
|
2025-12-15 |
Acquisition (Non Open Market) |
14,463 |
0.00 |
0.00 |
245,873 |
| MIST |
Milestone Pharmaceuticals Inc. |
Bharucha David |
|
2025-12-15 |
Sell |
58,007 |
2.32 |
134,576.24 |
105,326 |